This website uses cookies to enhance the user experience.
C

CAERUS CAPITAL AS984 276 141

Process industry
Limited company
c/o Torgeir Vaage Gabels gate 43A 0262 OSLO, Norge

CAERUS CAPITAL AS

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Organization

CEO
Chairman of the board
Years since formation
23 years
since Mar 9, 2002
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
1
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
1,589,969
NOK
Annual total result 2024
2,600,868
NOK
Total equity 2024
8,078,199
NOK
Last update: Jun 18, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
directly

Board

NameRoleShares
Chairman
100 %
directly

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
1
100 %

Shares owned by the CAERUS CAPITAL AS

NameShare classTotal number of sharesShare
P
PROPHYLIX PHARMA HOLDING AS
H-shares
6,000
0.99 %
A
ALGINOR ASA
NO0010756042
8,850
0.03 %
P
PROXIMAR SEAFOOD AS
NO0010893902
39,538
0.03 %
P
PARETO BANK ASA
NO0010397581
20,000
0.03 %
E
ELOPAK ASA
NO0011002586
1,607
< 0.01 %
V
Veidekke ASA
NO0005806802
500
< 0.01 %
S
STOREBRAND ASA
NO0003053605
3,500
< 0.01 %
A
AXACTOR ASA
NO0010840515
10,000
< 0.01 %
D
DNO ASA
NO0003921009
30,000
< 0.01 %
V
VÅR ENERGI ASA
NO0011202772
16,000
< 0.01 %
A
AKER HORIZONS ASA
NO0010921232
5,000
< 0.01 %
A
AUSTEVOLL SEAFOOD ASA
NO0010073489
5,000
< 0.01 %
S
SPAREBANK 1 SMN
NO0006390301
1,000
< 0.01 %
NO0003021909
35,000
< 0.01 %
K
KONGSBERG AUTOMOTIVE ASA
NO0003033102
10,000
< 0.01 %
N
NORDIC SEMICONDUCTOR ASA
NO0003055501
750
< 0.01 %
M
MOWI ASA
NO0003054108
500
< 0.01 %
K
KOMPLETT ASA
NO0011016040
850
< 0.01 %
T
TELENOR ASA
NO0010063308
1,000
< 0.01 %
Y
YARA INTERNATIONAL ASA
NO0010208051
1,150
< 0.01 %
A
AKER BP ASA
NO0010345853
600
< 0.01 %
M
MORROW BANK ASA
NO0010694029
5,000
< 0.01 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
1,589,969
1,237,928
0
0
Annual Total Result
2,600,868
2,722,406
-546,209
3,041,290
Total assets
9,669,476
8,979,535
6,245,773
6,485,687
Total liabilities
1,591,277
3,502,205
3,490,849
3,184,553
Total equity
8,078,199
5,477,331
2,754,925
3,301,134

P&L

Year2024202320222021
Total operating income
1,589,969
1,237,928
0
0
Total operating costs
31,177
22,228
21,443
22,125
Operating result
1,558,792
1,215,700
-21,443
-22,125
Financial income/costs
1,042,076
1,506,706
-524,766
3,063,415
Profit before tax
2,600,868
2,722,406
-546,209
3,041,290
Total tax & extraordinary income/cost
0
0
0
0
Annual Total Result
2,600,868
2,722,406
-546,209
3,041,290

Balance overview

Year2024202320222021
Total fixed assets
0
0
0
0
Total current assets
9,669,476
8,979,535
6,245,773
6,485,687
Total assets
9,669,476
8,979,535
6,245,773
6,485,687
Short term debt
38,086
228,682
288,307
3,184,553
Long term debt
1,553,191
3,273,523
3,202,542
0
Total liabilities
1,591,277
3,502,205
3,490,849
3,184,553
Contributed capital
3,438,652
3,438,652
3,438,652
3,438,652
Retained earnings
4,639,547
2,038,679
-683,727
-137,519
Total equity
8,078,199
5,477,331
2,754,925
3,301,134
Total equity and liabilities
9,669,476
8,979,536
6,245,774
6,485,687

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations